In this study based on the rat AA model of human RA, we observed that HLXL-treated rats had significantly reduced levels of chemokines (RANTES, MCP-1, MIP-1α, and GRO/KC) as well as matrix-degrading enzymes, MMP2 and MMP9. This evidence concerns the gene MMP9 and rheumatoid arthritis.